Research ExplorerPublicationsMonitoring serum free light chains in patients with multiple...

Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.

Standard

Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation. / Mösbauer, Ulrike; Ayuketang Ayuk, Francis; Schieder, Heike; Lioznov, Michael; Zander, Axel R.; Kröger, Nicolaus.

In: HAEMATOLOGICA, Vol. 92, No. 2, 2, 2007, p. 275-276.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Mösbauer, U, Ayuketang Ayuk, F, Schieder, H, Lioznov, M, Zander, AR & Kröger, N 2007, 'Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.', HAEMATOLOGICA, vol. 92, no. 2, 2, pp. 275-276. https://doi.org/10.3324/haematol.10568

APA

Mösbauer, U., Ayuketang Ayuk, F., Schieder, H., Lioznov, M., Zander, A. R., & Kröger, N. (2007). Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation. HAEMATOLOGICA, 92(2), 275-276. [2]. https://doi.org/10.3324/haematol.10568

Vancouver

Mösbauer U, Ayuketang Ayuk F, Schieder H, Lioznov M, Zander AR, Kröger N. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation. HAEMATOLOGICA. 2007;92(2):275-276. 2. https://doi.org/10.3324/haematol.10568

Bibtex

@article{48119a6ab4ce42069d3d1f3fe0067a94,
title = "Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.",
abstract = "Monitoring of serum free immunoglobulin light chains (FLC) in 26 myeloma patients who achieved immunofixation negativity after allografting showed a decrease of FLC at a median of 128 days before immunofixation negativity. In patients who subsequently relapsed, a 25% increase of FLC was observed at a median of 98 days before immunofixation positivity.",
author = "Ulrike M{\"o}sbauer and {Ayuketang Ayuk}, Francis and Heike Schieder and Michael Lioznov and Zander, {Axel R.} and Nicolaus Kr{\"o}ger",
year = "2007",
doi = "10.3324/haematol.10568",
language = "Deutsch",
volume = "92",
pages = "275--276",
journal = "HAEMATOLOGICA",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "2",

}

RIS

TY - JOUR

T1 - Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.

AU - Mösbauer, Ulrike

AU - Ayuketang Ayuk, Francis

AU - Schieder, Heike

AU - Lioznov, Michael

AU - Zander, Axel R.

AU - Kröger, Nicolaus

PY - 2007

Y1 - 2007

N2 - Monitoring of serum free immunoglobulin light chains (FLC) in 26 myeloma patients who achieved immunofixation negativity after allografting showed a decrease of FLC at a median of 128 days before immunofixation negativity. In patients who subsequently relapsed, a 25% increase of FLC was observed at a median of 98 days before immunofixation positivity.

AB - Monitoring of serum free immunoglobulin light chains (FLC) in 26 myeloma patients who achieved immunofixation negativity after allografting showed a decrease of FLC at a median of 128 days before immunofixation negativity. In patients who subsequently relapsed, a 25% increase of FLC was observed at a median of 98 days before immunofixation positivity.

U2 - 10.3324/haematol.10568

DO - 10.3324/haematol.10568

M3 - SCORING: Zeitschriftenaufsatz

VL - 92

SP - 275

EP - 276

JO - HAEMATOLOGICA

JF - HAEMATOLOGICA

SN - 0390-6078

IS - 2

M1 - 2

ER -